Comparison of SFRP4 concentrations between strata of categorical variables showed that SFRP4 levels were higher in patients with metabolic syndrome, insulin therapy, diabetes and a history of myocardial infarction or PCI (Table 4). This evidence concerns the gene INS and metabolic syndrome.